These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33115205)

  • 1. [Price analyses on direct-acting antiviral drugs of hepatitis C].
    Duan CAX; Sui BY; Chen ZD; Zhao K
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1161-1164. PubMed ID: 33115205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake of hepatitis C direct-acting antiviral treatment in China: a retrospective study from 2017 to 2021.
    Du X; Mi J; Cheng H; Song Y; Li Y; Sun J; Chan P; Chen Z; Luo S
    Infect Dis Poverty; 2023 Mar; 12(1):28. PubMed ID: 36978198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention and management of treatment failure to new oral hepatitis C drugs.
    Benítez-Gutiérrez L; Barreiro P; Labarga P; de Mendoza C; Fernandez-Montero JV; Arias A; Peña JM; Soriano V
    Expert Opin Pharmacother; 2016 Jun; 17(9):1215-23. PubMed ID: 27149603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Elimination of hepatitis C virus in Denmark].
    Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
    Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C elimination in Pakistan is a distant dream unless government controls the health sector.
    Altaf A; Pasha SK
    J Pak Med Assoc; 2020 Dec; 70(12(B)):2454-2456. PubMed ID: 33475562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
    Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
    BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathways to ensure universal and affordable access to hepatitis C treatment.
    Douglass CH; Pedrana A; Lazarus JV; 't Hoen EFM; Hammad R; Leite RB; Hill A; Hellard M
    BMC Med; 2018 Oct; 16(1):175. PubMed ID: 30296935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Progress, challenges and countermeasures of global hepatitis C elimination].
    Chen ZD
    Zhonghua Gan Zang Bing Za Zhi; 2020 Oct; 28(10):812-816. PubMed ID: 33105922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between rapid utilisation of direct hepatitis C antivirals and decline in the prevalence of viremia among people who inject drugs in Australia.
    Iversen J; Dore GJ; Catlett B; Cunningham P; Grebely J; Maher L
    J Hepatol; 2019 Jan; 70(1):33-39. PubMed ID: 30367897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan.
    Chang LJ; Chang HC; Chen PY; Chen CY; Tsai KF; Yean KK; Yang HY; Chen TH; Yu PT; Chou CK; Chen SH
    Medicina (Kaunas); 2022 Apr; 58(4):. PubMed ID: 35454360
    [No Abstract]   [Full Text] [Related]  

  • 12. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
    Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
    Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-world treatment for chronic hepatitis C infection in Germany: Analyses from drug prescription data, 2010-2015.
    Zimmermann R; Kollan C; Ingiliz P; Mauss S; Schmidt D; Bremer V
    J Hepatol; 2017 Jul; 67(1):15-22. PubMed ID: 28189752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of chronic viral hepatitis C with direct acting antiviral agent: review].
    Malov VA; Ubeeva EA; Ubeeva IP; Nikolaev SM; Umbetova KT
    Ter Arkh; 2019 Nov; 91(11):86-89. PubMed ID: 32598617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased peripheral CD4
    Langhans B; Nischalke HD; Krämer B; Hausen A; Dold L; van Heteren P; Hüneburg R; Nattermann J; Strassburg CP; Spengler U
    J Hepatol; 2017 May; 66(5):888-896. PubMed ID: 28040549
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the elimination of hepatitis C as a public health threat in Iceland: A goal attainable by 2020.
    Scott N; Ólafsson S; Gottfreðsson M; Tyrfingsson T; Rúnarsdóttir V; Hansdottir I; Hernandez UB; Sigmundsdóttir G; Hellard M
    J Hepatol; 2018 May; 68(5):932-939. PubMed ID: 29274408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personal, provider and system level barriers and enablers for hepatitis C treatment in the era of direct-acting antivirals: Experiences of patients who inject drugs accessing treatment in general practice settings in Australia.
    Heard E; Smirnov A; Massi L; Selvey LA
    J Subst Abuse Treat; 2021 Aug; 127():108460. PubMed ID: 34134878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescribing direct-acting antivirals to treat hepatitis C virus in a general practice setting in Australia: 'so why not do it'?
    Heard E; Massi L; Smirnov A; Selvey LA
    Intern Med J; 2020 Sep; 50(9):1053-1058. PubMed ID: 31589351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral drugs have made hepatitis C eminently treatable.
    Ladika S
    Manag Care; 2018 Nov; 27(11):23-30. PubMed ID: 30620304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of generic pan-genotypic sofosbuvir/velpatasvir versus genotype-dependent direct-acting antivirals for hepatitis C treatment.
    Goel A; Chen Q; Chhatwal J; Aggarwal R
    J Gastroenterol Hepatol; 2018 Dec; 33(12):2029-2036. PubMed ID: 29864213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.